Celsius Holdings, Inc. (OQ:CELH)
Business Focus: Non-Alcoholic Beverages
| Sector: Consumer Non-Cyclicals | Industry: Non-Alcoholic Beverages |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 2424 N. Federal Hwy, Suite 208 BOCA RATON FL 33431 |
| Tel: | N/A |
| Website: | https://www.celsiusholdingsinc.com |
| IR: | See website |
| Key People | ||
| John Fieldly Chairman of the Board, President, Chief Executive Officer | Jarrod Langhans Chief Financial Officer | Paul Storey Senior Vice President - Operations |
| Marcus Sandifer Vice President - Business and Legal Affairs, General Counsel, Corporate Secretary | Toby David Chief of Staff | Tony Guilfoyle Chief Commercial Officer |
| Business Overview |
| Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Celsius Holdings, Inc. revenues increased from $653.6M to $1.32B. Net income applicable to common stockholders totaled $182M vs. loss of $198.8M. Revenues reflect North America segment increase from $617.5M to $1.26B, Europe segment increase of 41% to $43.7M, other segment increase from $1.4M to $6.2M. Net Income reflects BOTTLED & CANNED SOFT DRINKS CARBONATED WATERS segment income totaling $266.4M vs. loss of $157.8M. |
| Employees: | 765 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $17,120M as of Dec 31, 2023 |
| Annual revenue (TTM): | $1,318M as of Dec 31, 2023 |
| EBITDA (TTM): | $277.60M as of Dec 31, 2023 |
| Net annual income (TTM): | $181.99M as of Dec 31, 2023 |
| Free cash flow (TTM): | $96.32M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 233,070,146 as of Apr 1, 2024 |
| Index Membership: | S&P 400 Mid Cap |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.